This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.
Diabetes, obesity & metabolism, 20(4), 889-897
Citation
Vilsbøll, Tina; Bain, Stephen C; Leiter, Lawrence A; Lingvay, Ildiko; Matthews, David; Simó, Rafael; Helmark, Ida Carøe; Wijayasinghe, Nelun; Larsen, Michael. (2018). Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.. Diabetes, obesity & metabolism, 20(4), 889-897. https://doi.org/10.1111/dom.13172